TapewireFind a company

person · Reporting owner

Turitz Andrew

Disclosed activity across 1 company

Tapewire entity
87765
SEC CIK
0001726221

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Teladoc Health, Inc.

Report date September 04, 2024 · Filed September 05, 2024

Section 16 reporting ended · disclosed 2024-09-05. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect20,773 Reported balance After 2024-09-04 transaction · row 1
1 source row

Row 1 · 2024-09-04 · Sale · Disposed 20,773 · Balance 20,773

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024.

Filing footnotes · ownership attribution and instrument terms

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 04, 2024 Filed Sep 5, 2024 16:05 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 20,773 $7.26 $150,811.98
Disclosure

SEC source: 0001477449-24-000198 · wk-form4_1725566712.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,773

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 1,617 $7.16 $11,584.19
Disclosure

SEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · nonDerivative · entry 4

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,546

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 3,100 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · derivative · entry 7

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,602

Underlying: Common Stock · 3,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 1,348 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · derivative · entry 6

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,696

Underlying: Common Stock · 1,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 1,056 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · derivative · entry 5

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,341

Underlying: Common Stock · 1,056 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 3,100 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · nonDerivative · entry 3

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,163

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 1,348 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,063

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 1,056 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,715

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 16:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 1,627 $11.16 $18,152.44
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 4

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,659

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 3,100 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 7

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,702

Underlying: Common Stock · 3,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 1,348 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 6

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,044

Underlying: Common Stock · 1,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 1,056 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 5

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,397

Underlying: Common Stock · 1,056 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 3,100 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 3

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,286

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 1,348 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,186

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 1,056 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 19, 2024 Filed Mar 20, 2024 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 GrantRestricted Stock Units · Derivative 43,800 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000072 · wk-form4_1710965460.xml · derivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,800

Underlying: Common Stock · 43,800 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

Read SEC document
March 05, 2024 Filed Mar 6, 2024 16:05 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 5,647 $14.53 $82,050.91
Disclosure

SEC source: 0001477449-24-000051 · wk-form4_1709759110.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,782

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 27, 2023.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 6,190 $14.52 $89,854.04
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 8

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,429

F4 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 1,148 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 15

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,148 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F13 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

F13 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 12,400 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 14

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,802

Underlying: Common Stock · 12,400 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F12 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F12 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 1,348 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 13

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,392

Underlying: Common Stock · 1,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F11 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F11 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 867 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 12

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 867 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

F10 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.

F10 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 437 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 11

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

F9 · derivative.exercise_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.

F9 · derivative.expiration_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 4,226 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 10

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,453

Underlying: Common Stock · 4,226 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

F8 · derivative.exercise_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F8 · derivative.expiration_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 GrantPerformance Stock Units · Derivative 12,679 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 9

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,679

Underlying: Common Stock · 12,679 shares

Expires not disclosed

F5 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock.

F6 · shares: Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.

F7 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F7 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 1,148 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 7

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 12,400 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 6

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,471

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 1,348 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 5

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,071

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 867 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 4

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,723

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 437 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 3

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 4,226 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

Read SEC document
March 01, 2024 Filed Mar 5, 2024 16:08 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 475 $15.06 $7,153.50
Disclosure

SEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,193

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 27, 2023.

Read SEC document
December 04, 2023 Filed Dec 5, 2023 16:05 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 397 $18.90 $7,504.09
Disclosure

SEC source: 0001477449-23-000099 · wk-form4_1701810338.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,668

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 16:05 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 1,347 $0.00 $0.00
Disclosure

SEC source: 0001477449-23-000099 · wk-form4_1701810338.xml · derivative · entry 3

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,740

Underlying: Common Stock · 1,347 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 16:05 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 1,347 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-23-000099 · wk-form4_1701810338.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,065

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
September 05, 2023 Filed Sep 6, 2023 16:17 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 396 $22.89 $9,066.02
Disclosure

SEC source: 0001477449-23-000043 · wk-form4_1694031417.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,718

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
September 01, 2023 Filed Sep 6, 2023 16:17 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 1,347 $0.00 $0.00
Disclosure

SEC source: 0001477449-23-000043 · wk-form4_1694031417.xml · derivative · entry 3

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,087

Underlying: Common Stock · 1,347 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
September 01, 2023 Filed Sep 6, 2023 16:17 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 1,347 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-23-000043 · wk-form4_1694031417.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
June 02, 2023 Filed Jun 5, 2023 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 386 $24.38 $9,411.07
Disclosure

SEC source: 0001415889-23-009203 · form4-06052023_080639.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,767

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 1,347 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-009203 · form4-06052023_080639.xml · derivative · entry 3

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,434

Underlying: Common Stock · 1,347 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 1,347 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-23-009203 · form4-06052023_080639.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,153

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 GrantRestricted Stock Units · Derivative 37,202 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004409 · form4-03072023_090301.xml · derivative · entry 2

Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,202

Underlying: Common Stock · 37,202 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F3 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 16:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 1,795 $25.91 $46,510.25
Disclosure

SEC source: 0001415889-23-004409 · form4-03072023_090301.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,806

F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 16:18 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 437 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 16

Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 437

Underlying: Common Stock · 437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

F13 · derivative.exercise_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.

F13 · derivative.expiration_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 16:18 UTC Teladoc Health, Inc. TDOC · Entity 1547 GrantPerformance Stock Units · Derivative 874 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 15

Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 874

Underlying: Common Stock · 874 shares

Expires not disclosed

F10 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock.

F11 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022.

F12 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023.

F12 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 16:18 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 867 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 14

Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 867

Underlying: Common Stock · 867 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.

F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 16:18 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 1,147 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 13

Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,148

Underlying: Common Stock · 1,147 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F8 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

F8 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 16:18 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 515 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 12

Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 515 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

F7 · derivative.exercise_date: On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.

F7 · derivative.expiration_date: On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 16:18 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 2,048 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 11

Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,048 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis

F6 · derivative.exercise_date: On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.

F6 · derivative.expiration_date: On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 16:18 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 1,205 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 10

Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,205 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

F5 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.